Skip to main content
Premium Trial:

Request an Annual Quote

GeneMatters, Concert Genetics Form Clinical Genetics Services Alliance

NEW YORK — GeneMatters and Concert Genetics said on Wednesday that they have signed an agreement to integrate their respective technologies into a clinical genetics services platform.

Under the terms of the deal, the companies will combine Concert's software-as-a-service platform for genetic test ordering and results management with GeneMatters' virtual genetic counselors, care delivery software, and patient engagement tools.

Financial and other terms of the agreement were not disclosed.

"By partnering with GeneMatters, we can combine their proven tech-enabled care delivery with Concert's test order management platform to provide seamless, end-to-end genetics services to leading healthcare organizations and the patients they serve," Concert CEO Rob Metcalf said in a statement.

Both companies have struck related deals with others in the past. In December, Nashville, Tennessee-based Concert partnered with Trapelo Health to offer technologies for oncology decision support. In mid-2019, Minneapolis-based GeneMatters formed an alliance with CancerIQ to provide genetic counseling services to high-risk cancer patients.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.